Day: May 13, 2021
Precision BioSciences Reports First Quarter and 2021 Financial Results and Provides Business Update
- Reacquired Global Development and Commercialization Rights to all Servier Partnered CAR T Programs, Including PBCAR0191 and PBCAR19B Stealth Cell - Expect to Present Updated PBCAR0191 Data in June at ASCO 2021 - Plan to Initiate Phase 1 Study of PBCAR19B Stealth Cell in Patients with R/R NHL by